Small drugmakers still scramble to survive

Published: 2013-08-21 06:59:00

Updated: 2013-08-21 06:59:00

Despite the recent report that revenues and operating profits of major drug companies surged 4.5 percent and 40 percent on-year, respectively, in the first half of this year, mid- or small-sized firms are seeking ways to compete at home as their profits continue to fall in the domestic market aft...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK